Stream 1 | Case Study
Montag, 19. September
14:55 - 15:20
Live in Berlin
Weniger Details
We all put our trust into pharmaceutical products and demand the highest production standards to ensure patient safety. The requirement to meet these higher standards has traditionally put pressure and limits on the industry regarding the implementation of new transformational technologies.
In recent years the pharmaceutical industry has been challenged to produce safe products at scale in record time-to-market. IoT-technologies have been key to meeting this challenge and continue to offer scope for further breakthroughs.
Darren O’Brien takes us in his presentation on the journey of how Amgen is improving outcomes by embracing Integration, Smart Analytics and next generation IOT technologies.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.